This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Zacks Investment Ideas feature highlights: Canopy Growth, Green Thumb Industries and AdvisorShares Pure US Cannabis ETF
by Zacks Equity Research
Canopy Growth, Green Thumb Industries and AdvisorShares Pure US Cannabis ETF have been highlighted in this Investment Ideas article.
Pot Stocks Surge on SAFE Banking Act Reintroduction
by Bryan Hayes
Lawmakers are attempting to make a final push toward delivering financial services for the cannabis industry.
Humana (HUM) Rewards Shareholders With a 12.4% Dividend Hike
by Zacks Equity Research
Humana's (HUM) capital position with strong cash-generating abilities and a solid balance sheet will likely sustain its shareholder-friendly moves.
Canopy Growth Corporation (CGC) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Canopy Growth Corporation (CGC) delivered earnings and revenue surprises of -169.23% and 11.85%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Phibro Animal Health (PAHC) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Phibro (PAHC) delivered earnings and revenue surprises of 13.33% and 2.58%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Will Canopy Growth Corporation (CGC) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed the most recent trading day at $2.38, moving -0.42% from the previous trading session.
Wednesday Recap: Minty Fresh Breadth
by Andrew Rocco
Breadth is an important measure used by investors to determine how strong or weak a market index is beneath the surface. Tuesday, the market flashed very strong breadth - an indication that bulls may be ready to take back the baton.
Canopy Growth Corporation (CGC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed the most recent trading day at $2.31, moving +1.32% from the previous trading session.
Canopy Growth Corporation (CGC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed the most recent trading day at $2.33, moving +1.75% from the previous trading session.
Canopy Growth Corporation (CGC) Stock Moves -0.38%: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed the most recent trading day at $2.60, moving -0.38% from the previous trading session.
Pot Stocks Get Smoked: What's Behind the Move?
by Andrew Rocco
Marijuana-related stocks reversed gains from earlier in the week as revelations emerged that a recent marijuana bill is unlikely to pass.
Canopy Growth Corporation (CGC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Canopy Growth Corporation (CGC) delivered earnings and revenue surprises of -55.56% and 0.87%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cardiovascular Systems (CSII) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of -12.50% and 0.58%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Nephros Inc. (NEPH) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Nephros Inc. (NEPH) delivered earnings and revenue surprises of 0% and 4.82%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for September 30th
by Zacks Equity Research
CGC, ESALY and META have been added to the Zacks Rank #5 (Strong Sell) List on September 30, 2022.
Canopy Growth Corporation (CGC) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Canopy Growth Corporation (CGC) delivered earnings and revenue surprises of -250% and 0.02%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Canopy Growth (CGC) This Earnings Season?
by Zacks Equity Research
Canopy Growth (CGC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Evolus, Inc. (EOLS) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Evolus, Inc. (EOLS) delivered earnings and revenue surprises of -58.33% and 0.90%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Canopy Growth Corporation (CGC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Canopy Growth Corporation (CGC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed at $2.54 in the latest trading session, marking a -0.97% move from the prior day.
Canopy Growth Corporation (CGC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed at $2.61 in the latest trading session, marking a +0.77% move from the prior day.
Canopy Growth Corporation (CGC) Stock Moves -0.87%: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed the most recent trading day at $2.29, moving -0.87% from the previous trading session.
Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Canopy Growth Corporation (CGC) closed at $2.81, marking a -1.4% move from the previous day.
Company News for May 31, 2022
by Zacks Equity Research
Companies in The News Are: PDD, CGC, COST, ULTA